Safety of statin therapy in HIV/hepatitis C virus-coinfected patients [4]

Journal of Acquired Immune Deficiency Syndromes

Volumn 46, Issue 2, 2007, Pages 258-260

  Milazzo, Laura ^a   Menzaghi, Barbara ^a   Corvasce, Stefano ^a   Bonfanti, Paolo ^a   Rusconi, Stefano ^a   Ridolfo, Anna Lisa ^a   Antinori, Spinello ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ATORVASTATIN; GAMMA GLUTAMYLTRANSFERASE; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; STATIN;

ALCOHOL ABUSE; CHI SQUARE TEST; CHRONIC LIVER DISEASE; DRUG SAFETY; FISHER EXACT TEST; GENOTYPE; HEPATITIS C VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERCHOLESTEROLEMIA; LETTER; LIPID METABOLISM; LIVER FUNCTION TEST; LIVER TOXICITY; PRIORITY JOURNAL; RANK SUM TEST;

ADULT; ALANINE TRANSAMINASE; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ASPARTATE AMINOTRANSFERASES; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HEPATITIS C; HIV INFECTIONS; HIV-1; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; LIVER; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 34748902292     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181142e43     Document Type: Letter

References (8)

1. Carr A, Samaras K, Thorisdottir A, et al. Diagnosis, prediction and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia and diabetes mellitus: a cohort study. Lancet. 1999;353:2093-2099.
2. de Denus S, Spinler SA, Miller K, et al. Statins and liver toxicity: a meta-analysis. Pharmacotherapy. 2004;24:584-591.
3. Khorashadi S, Hasson NK, Cheung RC. Incidence of statin hepatotoxicity in patients with hepatitis C. Clin Gastroenterol Hepatol. 2006;4:902-907.
4. Dubè MP, Stein JH, Aberg JA, et al. Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medicine Association of the Infectious Disease Society of America and Adult AIDS Clinical Trials Group. Clin Infect Dis. 2003;37:613-627.
5. Pasternak RC, Smith SC, Bairey-Merz CN, et al. ACC/AHA/NHLBI clinical advisory on the use and safety of statins. Circulation. 2002;106:1024-1028.
6. Gomez-Dominguez E, Gisbert JP, Moreno-Monteagudo JA, et al. A pilot study of atorvastatin treatment in dyslipemid, non-alcoholic fatty liver patients. Aliment Pharmacol Ther. 2006;23:1643-1647.
7. Greenwood J, Steinman L, Zamvil SS. Statin therapy and autoimmune disease: from protein prenylation to immunomodulation. Nat Rev Immunol. 2006;6:358-370.
8. Kwak B, Mulhaupt F, Myit S, et al. Statins as a newly recognized type of immunomodulator. Nat Med. 2000;6:1399-1402.